Your browser doesn't support javascript.
loading
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.
Perez-Correa, Andres; Abbas, Bilal; Riback, Lindsey; Ghiroli, Megan; Norton, Brianna; Murphy, Sean; Jakubowski, Andrea; Hayes, Benjamin T; Cunningham, Chinazo O; Fox, Aaron D.
Afiliación
  • Perez-Correa A; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America. Electronic address: a_perezcorrea@yahoo.com.
  • Abbas B; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America.
  • Riback L; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America.
  • Ghiroli M; Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States of America.
  • Norton B; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America; Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States of America.
  • Murphy S; Weill Cornell Medicine, Department of Population Health Sciences, 425 East 61st Street, Suite 301, New York, NY 10065-8722, United States of America.
  • Jakubowski A; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America; Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States of America.
  • Hayes BT; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America; Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States of America.
  • Cunningham CO; NYC Department of Health and Mental Hygiene, 42-09 28th Street, CN 2, Long Island City, NY 11101-4132, United States of America.
  • Fox AD; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States of America; Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States of America.
Contemp Clin Trials ; 114: 106674, 2022 03.
Article en En | MEDLINE | ID: mdl-34990854

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_sustancias_psicoativas / 4_aids / 8_opioid_abuse Asunto principal: Buprenorfina / Infecciones por VIH / Trastornos Relacionados con Opioides Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_sustancias_psicoativas / 4_aids / 8_opioid_abuse Asunto principal: Buprenorfina / Infecciones por VIH / Trastornos Relacionados con Opioides Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article
...